In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DOXY 200 Drug Master File in Korea (DOXY 200 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DOXY 200. The MFDS reviews the DOXY 200 KDMF as part of the drug registration process and uses the information provided in the DOXY 200 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DOXY 200 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DOXY 200 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DOXY 200 suppliers with KDMF on PharmaCompass.